- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 0.52 | 51.29 | -0.82 | 2.0 | 38.4 | 2.0 | N/A | - | ||
| 2024/2 | 0.34 | -69.87 | -23.09 | 1.48 | 60.66 | 2.21 | N/A | 因認列藥證移轉勞務收入與市場需求增加，故本年累計營收較去年同期增加。 | ||
| 2024/1 | 1.14 | 58.21 | 139.13 | 1.14 | 139.13 | 2.3 | N/A | 因適逢農曆春節連續假期備貨與藥證移轉勞務收入所致，故較去年同期增加。 | ||
| 2023/12 | 0.72 | 65.84 | 58.13 | 8.11 | 74.68 | 1.57 | 0.75 | 依據財務會計準則之相關規定，本公司併購創益公司，係屬集團內之組織重組，視為自始合併不受設立日之限制，故營收為合併淨額。 | ||
| 2023/11 | 0.43 | 4.27 | 11.55 | 4.53 | 8.19 | 1.28 | 0.92 | - | ||
| 2023/10 | 0.42 | -1.79 | 11.04 | 4.1 | 7.84 | 1.25 | 0.94 | - | ||
| 2023/9 | 0.42 | 4.01 | 3.48 | 3.68 | 7.49 | 1.24 | 0.62 | - | ||
| 2023/8 | 0.41 | 1.03 | 11.39 | 3.25 | 8.04 | 1.26 | 0.61 | - | ||
| 2023/7 | 0.4 | -9.74 | 17.25 | 2.85 | 7.57 | 1.27 | 0.6 | - | ||
| 2023/6 | 0.45 | 5.95 | 24.26 | 2.44 | 6.12 | 1.27 | 0.56 | - | ||
| 2023/5 | 0.42 | 6.49 | 15.8 | 1.99 | 2.75 | 1.23 | 0.58 | - | ||
| 2023/4 | 0.4 | -4.42 | 6.93 | 1.57 | -0.26 | 1.16 | 0.61 | - | ||
| 2023/3 | 0.42 | 19.85 | -1.94 | 1.17 | -2.47 | 1.17 | 0.51 | - | ||
| 2023/2 | 0.35 | -16.14 | 23.17 | 0.76 | -2.77 | 1.22 | 0.49 | - | ||
| 2023/1 | 0.41 | -9.43 | -17.36 | 0.41 | -17.36 | 1.26 | 0.48 | - | ||
| 2022/12 | 0.46 | 16.99 | 22.92 | 4.64 | 12.3 | 1.22 | 0.88 | - | ||
| 2022/11 | 0.39 | 3.8 | 7.69 | 4.19 | 11.26 | 1.18 | 0.91 | - | ||
| 2022/10 | 0.38 | -8.48 | 9.53 | 3.8 | 11.64 | 1.15 | 0.93 | - | ||
| 2022/9 | 0.41 | 11.96 | 16.24 | 3.42 | 11.87 | 1.12 | 0.56 | - | ||
| 2022/8 | 0.37 | 6.35 | 7.88 | 3.01 | 11.3 | 1.07 | 0.59 | - | ||
| 2022/7 | 0.34 | -4.34 | 16.53 | 2.65 | 11.79 | 1.07 | 0.59 | - | ||
| 2022/6 | 0.36 | -1.25 | 7.23 | 2.3 | 11.12 | 1.1 | 0.57 | - | ||
| 2022/5 | 0.36 | -1.66 | -0.36 | 1.94 | 11.87 | 1.16 | 0.53 | - | ||
| 2022/4 | 0.37 | -12.36 | 5.77 | 1.58 | 15.14 | 1.08 | 0.58 | - | ||
| 2022/3 | 0.42 | 50.56 | 8.84 | 1.2 | 18.38 | 1.2 | 0.51 | - | ||
| 2022/2 | 0.28 | -43.74 | 7.6 | 0.78 | 24.28 | 1.15 | 0.53 | - | ||
| 2022/1 | 0.5 | 34.72 | 36.15 | 0.5 | 36.15 | 1.23 | 0.49 | - | ||
| 2021/12 | 0.37 | 2.5 | -23.22 | 4.13 | -7.67 | 1.08 | 0.68 | - | ||
| 2021/11 | 0.36 | 5.57 | 2.73 | 3.76 | -5.79 | 1.06 | 0.69 | - | ||
| 2021/10 | 0.34 | -2.87 | -16.98 | 3.4 | -6.62 | 1.04 | 0.7 | - | ||
| 2021/9 | 0.35 | 3.9 | 17.21 | 3.06 | -5.29 | 0.99 | 0.74 | - | ||
| 2021/8 | 0.34 | 14.88 | -2.05 | 2.71 | -7.6 | 0.97 | 0.75 | - | ||
| 2021/7 | 0.3 | -11.98 | -16.57 | 2.37 | -8.35 | 1.0 | 0.73 | - | ||
| 2021/6 | 0.34 | -8.25 | 10.61 | 2.07 | -7.04 | 1.05 | 0.62 | - | ||
| 2021/5 | 0.37 | 4.39 | 37.68 | 1.73 | -9.83 | 1.11 | 0.59 | - | ||
| 2021/4 | 0.35 | -9.82 | 3.83 | 1.37 | -17.46 | 1.0 | 0.65 | - | ||
| 2021/3 | 0.39 | 48.85 | -8.88 | 1.02 | -22.91 | 1.02 | 0.74 | - | ||
| 2021/2 | 0.26 | -28.82 | -32.77 | 0.63 | -29.61 | 1.11 | 0.67 | - | ||
| 2021/1 | 0.37 | -24.03 | -27.18 | 0.37 | -27.18 | 1.2 | 0.62 | - | ||
| 2020/12 | 0.48 | 37.16 | 32.82 | 4.48 | -11.78 | 1.25 | 0.62 | - | ||
| 2020/11 | 0.35 | -14.69 | -13.6 | 4.0 | -15.22 | 1.07 | 0.73 | - | ||
| 2020/10 | 0.41 | 37.14 | -1.88 | 3.64 | -15.37 | 1.06 | 0.74 | - | ||
| 2020/9 | 0.3 | -13.17 | -38.32 | 3.23 | -16.84 | 1.0 | 0.88 | - | ||
| 2020/8 | 0.35 | -2.14 | -17.44 | 2.93 | -13.75 | 1.01 | 0.88 | - | ||
| 2020/7 | 0.35 | 16.7 | -12.58 | 2.58 | -13.22 | 0.92 | 0.95 | - | ||
| 2020/6 | 0.3 | 14.19 | -15.1 | 2.23 | -13.32 | 0.91 | 0.91 | - | ||
| 2020/5 | 0.27 | -21.26 | -35.32 | 1.92 | -13.04 | 1.08 | 0.77 | - | ||
| 2020/4 | 0.34 | -29.19 | -21.77 | 1.66 | -7.95 | 1.2 | 0.69 | - | ||
| 2020/3 | 0.48 | 22.73 | 28.54 | 1.37 | 0.07 | 1.37 | 0.42 | - | ||
| 2020/2 | 0.39 | -22.91 | 43.25 | 0.89 | -10.51 | 1.26 | 0.45 | - | ||
| 2020/1 | 0.5 | 38.57 | -30.59 | 0.5 | -30.59 | 1.28 | 0.45 | - | ||
| 2019/12 | 0.36 | -10.78 | -3.72 | 5.08 | -1.54 | 1.19 | 0.49 | - | ||
| 2019/11 | 0.41 | -3.11 | 11.81 | 4.71 | -1.37 | 1.32 | 0.45 | - | ||
| 2019/10 | 0.42 | -13.79 | 6.79 | 4.3 | -2.46 | 1.33 | 0.44 | - | ||
| 2019/9 | 0.49 | 16.21 | 29.6 | 3.88 | -3.37 | 1.31 | 0.35 | - | ||
| 2019/8 | 0.42 | 3.61 | 3.38 | 3.4 | -6.78 | 1.18 | 0.39 | - | ||
| 2019/7 | 0.41 | 13.34 | 22.43 | 2.98 | -8.06 | 1.17 | 0.39 | - | ||
| 2019/6 | 0.36 | -13.0 | -36.26 | 2.57 | -11.53 | 1.2 | 0.35 | - | ||
| 2019/5 | 0.41 | -4.76 | -12.3 | 2.21 | -5.61 | 0.0 | N/A | - | ||
| 2019/4 | 0.43 | 16.34 | 12.41 | 1.8 | -3.94 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 1.14 | 2023/1 | 0.41 | 2022/1 | 0.5 | 2021/1 | 0.37 | 2020/1 | 0.5 |
| 2024/2 | 0.34 | 2023/2 | 0.35 | 2022/2 | 0.28 | 2021/2 | 0.26 | 2020/2 | 0.39 |
| 2024/3 | 0.52 | 2023/3 | 0.42 | 2022/3 | 0.42 | 2021/3 | 0.39 | 2020/3 | 0.48 |
| N/A | N/A | 2023/4 | 0.4 | 2022/4 | 0.37 | 2021/4 | 0.35 | 2020/4 | 0.34 |
| N/A | N/A | 2023/5 | 0.42 | 2022/5 | 0.36 | 2021/5 | 0.37 | 2020/5 | 0.27 |
| N/A | N/A | 2023/6 | 0.45 | 2022/6 | 0.36 | 2021/6 | 0.34 | 2020/6 | 0.3 |
| N/A | N/A | 2023/7 | 0.4 | 2022/7 | 0.34 | 2021/7 | 0.3 | 2020/7 | 0.35 |
| N/A | N/A | 2023/8 | 0.41 | 2022/8 | 0.37 | 2021/8 | 0.34 | 2020/8 | 0.35 |
| N/A | N/A | 2023/9 | 0.42 | 2022/9 | 0.41 | 2021/9 | 0.35 | 2020/9 | 0.3 |
| N/A | N/A | 2023/10 | 0.42 | 2022/10 | 0.38 | 2021/10 | 0.34 | 2020/10 | 0.41 |
| N/A | N/A | 2023/11 | 0.43 | 2022/11 | 0.39 | 2021/11 | 0.36 | 2020/11 | 0.35 |
| N/A | N/A | 2023/12 | 0.72 | 2022/12 | 0.46 | 2021/12 | 0.37 | 2020/12 | 0.48 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 23Q4 (20) | 0.02 | 0 | -60.0 |
